Differentially expressed gene products in glioblastoma cells suppressed for tumorigenicity

Reference

• Altschul S. F., Gish W., Miller W., Myers E. W., Lipman DJ. Basic local alignment search tool. J Mol Biology 1990; 215: 403–410
   PubMed Web of Science ®Google Scholar
• Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidilic acid-cellulose. Proc Natl Acad Sci USA 1972; 69: 1408–1412
   PubMed Web of Science ®Google Scholar
• Bigner S. H., Mark H., Burger P. C., Mahaley M. S., Bullar D. E., Mughlbaier L. H., Bigner DD. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 1988; 88: 405–411
   Google Scholar
• Bigner S. H., Mark J., Bigner DD. Cytogenetics of human brain tumors. Cancer Genet Cytogenet 1990; 47: 141–154
   PubMed Web of Science ®Google Scholar
• Chirgwin J. J., Przbyla A. E., Macdonald R. J., Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemstry 1979; 18: 52–94
   Google Scholar
• Connor J. R., Boeshore K. L., Benkovic S. A., Menzies SL. Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 1994; 37: 461–465
   PubMed Web of Science ®Google Scholar
• Davis MM. Subtractive cDNA hybridization and the T-cell receptor genes. Handbook of Experimental Immunology, DM Weir, LA Herzenberg, C Blackwell, LA Herzenberg, 1986; Vol.2: 76.1–76.13.
   Google Scholar
• El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, A potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825
   PubMed Web of Science ®Google Scholar
• Feinberg A., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1984; 132: 6–13
   Web of Science ®Google Scholar
• Fults D., Pedone CA. Deletion mapping of the long arm of chromosomes 10 in glioblastoma multiforme. Genes Chromom Cancer 1992; 7: 173–177
   Google Scholar
• Fults D., Pedone C. A., Thomas G. A., White R. Allelotype of human malignant astrocytoma. Cancer Res 1990; 50: 5784–5789
   PubMed Web of Science ®Google Scholar
• Fults D., Petronio J., Noblett B. D., Pedone CA. Chromosome 11 p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. Genomics 1992; 14: 799–801
   Google Scholar
• Fults D., Tippets R. H., Thomas G. A., Nakamura Y., White R. Loos of heterozygosity for loci on chromosome 17p in human malignant astrocytomas. Cancer Res 1989; 49: 6572–6577
   PubMed Web of Science ®Google Scholar
• Hsu S. C., Volpert O. V., Steck P. A., Mikkelsen T., Polverini P. J., Rao S., Chou P., Bouck NP. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 1996; 56: 5684–5691
   PubMed Web of Science ®Google Scholar
• James C. D., He J., Carlbom E., Nordenskjold M., Cavenee W. K., Collins VP. Chromosomes 9 deletion mapping reveals interferon a and interferonβ-l gene deletions in human glial tumors. Cancer Res 1991; 51: 1684–1688
   PubMed Web of Science ®Google Scholar
• James D., Carlbom E., Dumanski J., Hansen M., Nordenskjold M., Collins V. P., Cavanee W. Clonal genomic alterations in glioma malignancy stages. Cancer Res 1988; 48: 5546–5551
   PubMed Web of Science ®Google Scholar
• Khan A. S., Wilcox A. S., Polymeropoulos M. H., Hopkins J. A., Stevens T. J., Robinson M., Orpana A. K., Sikela JM. Single pass sequencing and physical and genetic mapping of human brain cDNAs. Nature Genetics 1992; 2: 180–185
   PubMedGoogle Scholar
• Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S. I., Puc J., Miliaresis C., Rodgers L., Mccombie R., Bigner S. H., Giovanella B. C., Ittmann M., Tycko B., Hibhoosh H., Wigler M. H., Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943–1947
   PubMed Web of Science ®Google Scholar
• Ligon A. H., Pershouse M. A., Jasser S. A., Yung WKA, Steck PA. Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma. Onco-gene 1997; 14: 1075–1081
   Google Scholar
• Mollenhauer J., Wiemann S., Scheurlen W., Korn B., Hayashi Y., Wilgenbus K. K., Von Deimling A., Poutska A. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours. Nature Genetics 1997; 17: 32–39
   PubMed Web of Science ®Google Scholar
• Myers M. P., Stolarov J. P., Eng C., Li J., Wagner I., Wigler M. H., Parsons R., Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 1997; 94: 9052–9057
   PubMed Web of Science ®Google Scholar
• Nister M., Hammacher A., Mellstrom K., Siegbahn A., Ronnstrand L., Westermark B., Heldin C-H. A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 1988; 52: 791–799
   PubMed Web of Science ®Google Scholar
• Pang JCS, Du R. P., Bingham H., Juranka P., Chan V-L. Imbalance of purine nucleotides in alanosine-resistant baby hamster kidney cells. Somatic Cell Mol Genet 1989; 15: 101–111
   Google Scholar
• Pershouse M. A., Stubblefield E., Hadi A., Killary A. M., Yung WKA, Steck PA. Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res 1993; 53: 5043–5050
   PubMed Web of Science ®Google Scholar
• Pringle N., Collarini E. J., Mosely M. J., Heldin C-H, Wester-Mark B., Richardson WD. PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cell in the developing rat optic nerve. EMBO J 1989; 8: 1049–1056
   PubMed Web of Science ®Google Scholar
• Raff M. C., Miller R. H., Noble M. A glial progenitor cell that develops in vitro into an astroctye or an oligodendrocyte depending on culture medium. Nature (Lond) 1983; 274: 813–816
   Google Scholar
• Ransom D. T., Ritland S. R., Kimmel D. W., Moertel C. A., Dahl R. J., Scheithauer B. W., Kelly P. J., Jenkins RB. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligoden-drogliomas. Genes Chromosom Cancer 1992; 5: 348–356
   PubMed Web of Science ®Google Scholar
• Rasheed BKA, Fuller G. N., Friedman A. H., Bigner D. D., Bigner SH. Loss of heterozygosity for 10q loci in human gliomas. Genes Chromom Cancer 1992; 5: 75–82
   PubMed Web of Science ®Google Scholar
• Rasheed BKA, Mclendon R. E., Friedman H. S., Friedman A. H., Fuchs H. E., Biger D. D., Bigner SH. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25. Oncogene 1995; 12: 2244–2247
   Google Scholar
• Ritland S. R., Ganju V., Jenkins RB. Region-specific loss of heterozygosity on chromosome 19 is related to the morphologic type of human glioma. Genes Chromosom Cancer 1995; 12: 277–282
   PubMedGoogle Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. Second. Cold Spring Harbor Laboratory Press. 1989
   Google Scholar
• Sharp MGF, Admas S. M., Walker R. A., Brammar W. J., Varley JM. Differential expression of the mitochondrial gene cytochrome oxidase II in benign and malignant breast tissue. J Pathology 1992; 168: 163–168
   PubMed Web of Science ®Google Scholar
• Steck P. A., Ligon A. H., Cheong P., Yung WKA, Pershouse MA. Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromsom Cancer 1995; 12: 255–261
   PubMed Web of Science ®Google Scholar
• Steck P. A., Pershouse M. A., Jasser S. A., Yung WKA, Lin H., Ligon A. H., Langford L. A., Baumgard M. L., Hattier T., Davis T., Fyre C., Hu R., Swedlund B., Teng DHF, Tavtigian S. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 1997; 15: 356–362
   PubMed Web of Science ®Google Scholar
• Stehelin D., Guntaka R. V., Varmus H. E., Bishop JM. Purification of DNA complementary to nucleotide sequences required for neoplastic transformation of fibroblasts by avian sarcoma viruses. J Mol Biol 1976; 101: 349–365
   PubMed Web of Science ®Google Scholar
• Stubblefield E., Pershouse M. Direct formation of microcells from mitotic cells for use in chromosome transfer. Somatic Cell Mol Genet 1992; 18: 485–491
   PubMedGoogle Scholar
• Vayssiere J-C, Cordeau-Lossouarn L., Larcher J. C., Basse-Ville M., Gros F., Croizal B. Participation of the mitochondrial genome in the differentiation of neuroblastoma cells. In Vitro Cell Dev Biol 1994; 28A: 763–772
   Google Scholar
• Von Deimling A., Louis D. N., Von Ammon K., Petersen I., Hoell T., Chung R. Y., Martuza R. L., Schoenfeld D. A., Yasrgil M. G., Wiestler OD. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 1992; 77: 295–301
   PubMed Web of Science ®Google Scholar
• Williams K. A., Deber CM. The structure and function of central nervous system myelin. Crit Rev Clin Lab Sci 1993; 30: 29–64
   Web of Science ®Google Scholar
• Wong A. J., Bigner S. H., Bigner D. D., Kinzler K. W., Hamilton S. R., Vogelstein B. Increased expression of the EGF receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 1987; 84: 6899–6903
   PubMed Web of Science ®Google Scholar
• Yung WKA, Lotan R., Lee P., Lotan D., Steck PA. Modulation of growth and epidermal growth factor receptor activity by retinoic acid in human glioma cells. Cancer Res 1989; 49: 1014–1019
   Google Scholar